id: NEW:medication_dose_adjustment_telemedicine_to_NEW:glycemic_control_hba1c
name: Medication Dose Adjustment via Telemedicine â†’ Glycemic Control (HbA1c Levels)
from_node:
  node_id: NEW:medication_dose_adjustment_telemedicine
  node_name: Medication Dose Adjustment via Telemedicine
to_node:
  node_id: NEW:glycemic_control_hba1c
  node_name: Glycemic Control (HbA1c Levels)
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Telemedicine platforms enable remote communication between healthcare providers
  and patients with Type 1 diabetes mellitus, allowing for real-time data sharing
  and consultation'
- 'Step 2: Providers use transmitted glucose monitoring data and clinical information
  to make timely medication dose adjustments (insulin titration) without requiring
  in-person visits'
- 'Step 3: More frequent and responsive medication adjustments optimize insulin dosing,
  reducing periods of hyperglycemia and improving overall glycemic control'
- 'Step 4: Improved glycemic control through optimized medication management results
  in lower HbA1c levels over time'
evidence:
  quality_rating: A
  n_studies: 20
  primary_citation: 'Kun Zhang et al. 2023. Telemedicine in Improving Glycemic Control
    Among Children and Adolescents With Type 1 Diabetes Mellitus: Systematic Review
    and Meta-Analysis. Journal of Medical Internet Research.'
  supporting_citations: []
description: Telemedicine-enabled medication dose adjustment significantly reduces
  HbA1c levels in children and adolescents with Type 1 diabetes mellitus. A meta-analysis
  of 20 RCTs found that telemedicine interventions with medication dose adjustment
  capabilities reduced HbA1c by 0.25 percentage points compared to usual care. This
  effect is driven by the ability of healthcare providers to make timely insulin dose
  modifications based on remotely transmitted glucose data, enabling more responsive
  and personalized diabetes management.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: -0.25
    type: mean_difference
    ci_lower: -0.37
    ci_upper: -0.12
  p_value: 0.001
  sample_size: 1704
moderators:
- name: Age group
  direction: strengthens
  strength: moderate
  description: Effect of telemedicine on HbA1c appeared greater in studies involving
    children (MD -0.41) compared to adolescents
- name: Study duration
  direction: strengthens
  strength: moderate
  description: Studies lasting <6 months showed greater effect (MD -0.32) compared
    to longer duration studies
- name: Communication modality
  direction: strengthens
  strength: strong
  description: Studies where providers used smartphone apps to communicate with patients
    showed greater effect (MD -0.37)
